I am very honored to be part of the 2021 #40Under40inCancer Rising Stars & Emerging Leaders!.This award recognizes the nation’s most promising young oncology professionals and celebrates our contributions to improve the lives of those affected by cancer.@MDAndersonNews @PCFnews

☑️223Ra-mediated trabecular bone loss was prevented by administration of zoledronic acid, which should 👉always be combined with 223Ra👈

☑️ 223Ra impaired osteoblast bone-forming activity, paralleled by a transient increase in osteoclast number and long-term adipocyte formation. Overall, these results suggest that the impact of 223Ra on bone health is orchestrated by multiple bone stromal cell components

☑️223Ra caused major trabecular bone loss with an impact on trabecular bone mechanical properties, and no detectable effects on cortical bone

☑️ In our work, we combined micro-computed tomography and mechanical studies with ex vivo spatial biology analysis based on 3D fluorescence microscopy to clarify the effects of 223Ra on bone and key bone stromal cell components

☑️ A recent prospective clinical study has shown a significantly increased fracture rate associated with the administration of 223Ra, mostly in tumor-free bones.

☑️ #223Ra is a bone-seeking, a-particle-emitting radionuclide approved for patients with metastatic prostate cancer, currently tested in clinical trials for primary and metastatic cancers to the bone.

🔥HOT OFF THE PRESS🔥.Our latest paper by @sergio_42 on the effects of #Radium223 on the #BoneMicroenvironment is out in @ActaPharmSinB !. Check it out here 👇.. #BoneMetsLab

RT @oncodaily: Great Start to the Weekend with Kidney Cancer Association's 81K Houston Walk - Matt Campbell (@DocMattCampbell). @KidneyCanc….

RT @mjmoussa_: 🎉 One of our FAVORITE events of the year, moving for 81’ in beautiful Hermann Park #Houston for the KCA’s 81K Fundraising Ch….

RT @DocMattCampbell: Great start to the weekend with @KidneyCancer 81K Houston walk with @MDAndersonNews in honor of those who will diagnos….

RT @PavlosMsaouel: 1/5 People living with sickle-cell disease (SCD) face ↑ cancer risk, including #RenalMedullaryCarcinoma. Our latest @Imm….

Congratulations to our talented PhD students @ElisaSerafini7 (co-sup by #DrCasarin) & @LudovicaLaPosta, who ranked 2nd and 3rd out of 50+ trainees in the competition named in memory of our former student, Giorgio Allegri.This achievement is particularly significant for our lab ❤️

More great science from our Senior Investigators .@ISSNAF_WSC @FrancyPolverino @astro_luca @LabGenovese #AnnalisaQuaini.#GiornataDellaRicercaItalianaNelMondo

Spotlight on Emerging Investigators at the #GiornataDellaRicercaItalianaNelMondo.It was an awesome multidisciplinary session! @ISSNAF_WSC #MarcoDeGiorgi @cesconmarzia @Anna_Fracassi @spacecoom

Our goal, today, is to celebrate #Italian scientific excellence, support the internationalization of national research institutions, and foster new collaborations with key stakeholders in research and technology transfer.

The #GiornataDellaRicercaItalianaNelMondo is an annual initiative promoted by the Italian Ministry of Foreign Affairs and International Cooperation.

Today, as @ISSNAF_WSC, together with #ComitesHouston and the #ConsulateGeneralOfItalyInHouston, we are delighted to celebrate the VIII Edition of the Italian Research Day in the World.

RT @DocMattCampbell: 3rd annual UT Christopher G Wood advances in urologic oncology symposium in Austin. Appreciate all who traveled in for….

RT @oncodaily: Congrats to Stefan Maksimović for receiving a KidneyCAN-AACR scholar-in-training award - Eleonora Dondossola. @ED_PhD_ @AAC….

Big congrats to @dr4gut1n, a senior postdoc in the lab co-mentored by @DocMattCampbell,.for receiving a @kidneycan.@AACR scholar-in-training award!.Way to go, Stefan!.#AACR25 #CancerResearch .#KidneyCancer.#AACRScholars